Tower Research Capital LLC (TRC) - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$14,245
+66.0%
4,508
+103.3%
0.00%
Q2 2023$8,580
+65900.0%
2,217
-53.2%
0.00%
Q1 2023$13
+30.0%
4,733
-18.6%
0.00%
Q4 2022$10
-99.9%
5,812
-6.8%
0.00%
Q3 2022$13,000
-75.0%
6,235
-68.0%
0.00%
-100.0%
Q2 2022$52,000
+372.7%
19,486
+705.2%
0.00%
Q1 2022$11,000
-21.4%
2,420
-5.8%
0.00%
Q4 2021$14,000
+133.3%
2,570
+157.0%
0.00%
Q3 2021$6,0001,0000.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders